Management of immune thrombotic thrombocytopenic purpura with caplacizumab: a Canadian, single-centre, real-world experience-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Management of immune thrombotic thrombocytopenic purpura with caplacizumab: a Canadian, single-centre, real-world experience

Published:2023-01-13 Issue:1 Volume:34 Page:
ISSN:0953-7104
Container-title:Platelets
language:en
Short-container-title:Platelets

Author:

Tse Brandon¹²,Buchholz Megan³,Pavenski Katerina¹²⁴⁵

Affiliation:

1. Division of Hematology, Department of Medicine, St. Michael’s Hospital, Toronto, ON, Canada

2. Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada

3. Kidney and Metabolism Program, St. Michael’s Hospital, Toronto, ON, Canada

4. Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada

5. Department of Laboratory Medicine, St. Michael’s Hospital, Toronto, ON, Canada

Funder

no funding

Publisher

Informa UK Limited

Subject

Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/09537104.2022.2157807

Reference27 articles.

1. Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015

2. ISTH guidelines for treatment of thrombotic thrombocytopenic purpura

3. Evaluation of efficacy and safety of the anti-VWF Nanobody ALX-0681 in a preclinical baboon model of acquired thrombotic thrombocytopenic purpura

4. Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura

5. Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of clinical factors in first diagnosis of immune thrombotic thrombocytopenic purpura with report of 6 cases;2024-06-07

2. ADAMTS13 recovery in acute thrombotic thrombocytopenic purpura after caplacizumab therapy;Blood;2024-05-02

3. Caplacizumab;Reactions Weekly;2024-04-06

4. Real-World Data Analysis of Patients Affected by Immune-Mediated Thrombotic Thrombocytopenic Purpura in Italy;Journal of Clinical Medicine;2024-02-27

5. Should we consider caplacizumab as routine treatment for acute thrombotic thrombocytopenic purpura? An expert perspective on the pros and cons;Expert Review of Hematology;2024-02-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3